SFO
TARO

Stokes Family Office’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Stokes Family Office’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,750
Closed -$286K – 338
2023
Q1 		$286K Buy
11,750
+1,150
+11% +$28K 0.04% 228
2022
Q4 		$308K Buy
+10,600
New +$308K 0.04% 214